Blood cancers, Polycythaemia, Thrombocythaemia
Results
Phase 3
This trial compared a pegylated interferon with hydroxyurea. It was for polycythaemia vera and essential thrombocythaemia.
The trial was supported by Cancer Research UK. It was open for people to join between 2011 and 2016. The research team published the results in 2022.
Recruitment start: 1 September 2011
Recruitment end: 30 June 2016
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Claire Harrison
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
Guy's and St Thomas' NHS Foundation Trust
Mario Negri (IRCCS)
Myeloproliferative Disorders Research Consortium (USA)
NIHR Clinical Research Network: Cancer
Roche
This is Cancer Research UK trial number CRUK/11/048.
Last reviewed: 29 November 2022
CRUK internal database number: 8124